Our Pricing

Mounjaro WEIGHTLOSSNEW Discount - GPhC Registered UK Pharmacy

Published on: June 03, 2026

Searching for a mounjaro weightlossnew discount uk pharmacy you can trust? Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) from £124.99 with transparent upfront pricing, free clinical consultations under 3 minutes, and discreet next-day delivery. Our GPhC-registered team (Superintendent Pharmacist Tarun Kumar, GPhC 2233073) ensures every prescription is clinically assessed by UK prescribers before dispensing.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike older single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously. This dual action enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite more effectively than GLP-1-only therapies [1].

In the landmark SURMOUNT-1 trial, adults receiving the highest maintenance dose (15 mg once weekly) achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than placebo and comparable single-pathway alternatives [2]. Participants also reported improved cardiometabolic markers, including reductions in waist circumference, blood pressure, and HbA1c levels, even in those without type 2 diabetes [2].

Mounjaro is administered as a once-weekly subcutaneous injection using the convenient KwikPen device. Dosing begins at 2.5 mg weekly for four weeks, then escalates gradually to minimise gastrointestinal side effects. Your UK prescriber will determine your optimal maintenance dose (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) based on your clinical response and tolerability during follow-up consultations [3].

Mounjaro WEIGHTLOSSNEW Discount: What You Need to Know

At Cured Pharmacy, we provide genuine Mounjaro from £124.99 with no hidden fees or surprise charges at checkout. Our transparent pricing model shows the exact cost before you complete your free online consultation, so you can make an informed decision without guesswork. This is part of our commitment to lowest prices guaranteed across the UK.

Promotional discount codes may be available periodically for weight loss treatments, offering savings on your first order or multi-month supplies. To access current offers, simply start your free clinical assessment and enter any applicable code at checkout. All Mounjaro prescriptions require approval by a UK-registered prescriber following MHRA and NICE guidelines, ensuring clinical safety and suitability [4].

Unlike some online providers, Cured Pharmacy never compromises on quality or regulatory compliance to reduce prices. Every Mounjaro pen is sourced directly from UK-licensed wholesalers, stored in GPhC-compliant facilities, and dispensed by our qualified pharmacy team. You receive the same pharmaceutical-grade medication available through high-street pharmacies, but with the convenience of discreet home delivery and competitive online pricing.

How to Apply Your Discount Code

Start your free online consultation by clicking 'Start Assessment' on the Mounjaro product page. Complete the clinical questionnaire honestly — your UK prescriber will review your medical history, current medications, and weight loss goals to determine suitability. If approved, enter your discount code during checkout to apply savings automatically. Your prescription is then fulfilled by our GPhC-registered pharmacy team and dispatched in 100% discreet packaging, typically arriving within 1-2 working days via tracked courier.

Comparing Mounjaro to Other Weight Loss Treatments

The UK weight loss medication landscape includes several MHRA-licensed options, each with distinct mechanisms, dosing schedules, and clinical efficacy profiles. Mounjaro (tirzepatide) represents the newest generation, offering dual-receptor activation that clinical trials suggest may produce greater weight reduction than older GLP-1-only therapies [2][5].

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [5]. Saxenda (liraglutide) is a daily injection producing average weight loss of 8% over 56 weeks in the SCALE trials [6]. Orlistat-based treatments (Xenical, Orlos, Alli) work by blocking dietary fat absorption rather than affecting appetite hormones, typically resulting in 5-10% weight reduction when combined with a reduced-calorie diet [7].

Your UK prescriber will consider your BMI, medical history, previous weight loss attempts, and personal preferences when recommending the most appropriate treatment. Factors such as injection frequency, side effect profiles, contraindications, and budget all influence the decision. Some patients achieve better results with daily injections like Saxenda due to consistent appetite suppression, while others prefer the convenience of once-weekly Mounjaro or Wegovy.

Clinical Trial Data: Head-to-Head Comparisons

The SURPASS-2 trial directly compared tirzepatide to semaglutide 1 mg in adults with type 2 diabetes. Participants receiving tirzepatide 15 mg achieved significantly greater HbA1c reductions and weight loss (average 12.4 kg) compared to those on semaglutide 1 mg (average 6.2 kg) over 40 weeks [8]. While this study focused on diabetes management, the weight loss findings informed tirzepatide's subsequent licensing for obesity treatment. Both medications share similar side effect profiles, predominantly gastrointestinal symptoms that typically diminish with continued use and gradual dose escalation [8].

Who Can Use Mounjaro for Weight Loss?

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [3]. Your UK prescriber will calculate your BMI during the online consultation and assess whether you meet MHRA licensing criteria.

Certain medical conditions preclude Mounjaro use. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, diabetic ketoacidosis, and pregnancy or breastfeeding [3]. Your prescriber will review your full medical history, current medications, and any allergies to ensure Mounjaro is safe and appropriate for you.

If Mounjaro is not suitable, your UK prescriber may recommend alternative treatments available through Cured Pharmacy. Wegovy and Saxenda offer proven weight loss efficacy with slightly different mechanisms and dosing schedules. Orlistat-based treatments provide a non-injection option for patients who prefer oral capsules or have contraindications to GLP-1 therapies. Every recommendation is personalised to your clinical profile and weight loss objectives.

Starting Mounjaro: What to Expect

Mounjaro treatment begins with a 2.5 mg once-weekly injection for the first four weeks. This starter dose allows your body to adjust to the medication and minimises gastrointestinal side effects such as nausea, vomiting, and diarrhoea. After four weeks, your prescriber will increase the dose to 5 mg weekly, with further escalations every four weeks until you reach your optimal maintenance dose [3].

Most patients experience appetite reduction within the first week of treatment. You may notice feeling fuller after smaller meals, reduced cravings for high-calorie foods, and less frequent hunger between meals. Weight loss typically becomes noticeable after 4-8 weeks, with the most significant reductions occurring between weeks 20 and 72 as you reach higher maintenance doses [2].

Mounjaro works best when combined with a reduced-calorie diet and increased physical activity. Your UK prescriber will provide lifestyle guidance tailored to your starting point and goals. Regular follow-up consultations (typically every 4-12 weeks) allow your prescriber to monitor progress, adjust dosing, manage side effects, and provide ongoing support. If you do not achieve at least 5% weight loss after 16 weeks on the maximum tolerated dose, your prescriber may recommend discontinuing Mounjaro and exploring alternative treatments [3].

Managing Side Effects

Gastrointestinal symptoms are the most common side effects, affecting up to 30% of patients in clinical trials [2]. These typically include nausea, diarrhoea, constipation, vomiting, and abdominal discomfort. Symptoms are usually mild to moderate, occurring most frequently during dose escalation, and resolve within a few weeks as your body adapts. Eating smaller meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week can help minimise discomfort. If side effects persist or become severe, contact your prescriber — they may slow dose escalation or adjust your treatment plan.

Why Choose Cured Pharmacy for Mounjaro?

Cured Pharmacy is a fully GPhC-registered online pharmacy (Registration Number 9012511) operating under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We dispense only genuine UK-licensed medications sourced from MHRA-approved wholesalers, ensuring every Mounjaro pen meets the same pharmaceutical standards as high-street pharmacies.

Our free online consultation takes under 3 minutes to complete and is reviewed by experienced UK-registered prescribers, typically within 24 hours. We provide transparent upfront pricing with no hidden fees — the price you see is the price you pay, with delivery included. All orders are dispatched in 100% discreet packaging via tracked courier, arriving within 1-2 working days to any UK address.

If you have questions about Mounjaro, dosing, side effects, or your prescription, our qualified pharmacy team is available by phone (+44 116 4646009) or email. We're committed to providing expert clinical support throughout your weight loss journey, from initial consultation through ongoing treatment and follow-up care. Your health and safety are our top priorities, which is why every prescription undergoes rigorous clinical review before dispensing.

Our Lowest Price Guarantee

We continuously monitor UK market pricing to ensure Cured Pharmacy offers the most competitive rates available. If you find a lower price for the same Mounjaro dose from another GPhC-registered UK pharmacy, contact our team — we'll match or beat that price. Our commitment to affordability never compromises pharmaceutical quality, regulatory compliance, or patient safety. You receive genuine medication, expert clinical oversight, and discreet professional service at the lowest possible cost.

Scientific References

1. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14269 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. https://www.nice.org.uk/guidance/ta924 [accessed 13 August 2026]
5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
7. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
8. Frías, J. P., et al. (2021). Efficacy and safety of tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10295), 64–77. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary — weight loss figures cited are averages from clinical trials and do not guarantee specific outcomes.